US Patent 10329582 Genetic modification of rats
Patent 10329582 was granted and assigned to Regeneron Pharmaceuticals on June, 2019 by the United States Patent and Trademark Office.
Name
# Contributions
Last Contribution
Find more entities like US Patent 10329582 Genetic modification of rats
Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.
